Clackson Timothy P
- SEC CIK
- 0001242992
No open-market purchases or sales filed in the past year.
Current role at each company
- Elevation Oncology, Inc.Directoras of Jul 24, 2025
- THRX Theseus Pharmaceuticals, Inc.President and CEOas of Mar 2, 2023
- FMTX Forma Therapeutics Holdings, Inc.Directoras of Oct 14, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Clackson Timothy P as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
THRX Theseus Pharmaceuticals, Inc.
President and CEO2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 14, 2022 (view filing) | Nov 11 | 3 days | Clackson Timothy PPresident and CEO | PPurchase | +2.50K | $6.80 | +$17.0K | +0.7%351.0K after | |
| Dec 22, 2021 (view filing) | Dec 21 | 1 day | Clackson Timothy PPresident and CEO | PPurchase | +2.60K | $9.76 | +$25.4K | +0.8%348.5K after |